Suppr超能文献

CD10在皮肤基底细胞癌和鳞状细胞癌中的免疫组化表达

Immunohistochemical Expression of CD10 in Cutaneous Basal and Squamous Cell Carcinomas.

作者信息

Aiad Hayam A, Hanout Hayam M

机构信息

The Departments of Pathology and Dermatology & Andrology, Faculty of Medicine, Menofiya University.

出版信息

J Egypt Natl Canc Inst. 2007 Sep;19(3):195-201.

Abstract

Background : CD10 is a zinc-dependent metallopeptidase known as common acute lymphoblastic leukemia antigen (CALLA). Although CD10 expression has been investigated in some cutaneous tumors, to our knowledge, data regarding its expression in cutaneous epithelial neoplasms are very limited. We aimed to determine the immunohistochemical expression of CD10 in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) and to associate it with the available clinicopathological parameters in both tumors. Patients and Methods : This study included 16 SCC and 21 BCC cases (17 solid type, 2 morphea type and 2 adenoid basal types). BCC cases were divided into 12 cases with microscopic infiltrative base and 9 cases with well-circumscribed base. The localization of anti-CD10 to the tumor and/or stromal cells was determined in each case. Results : Positive CD10 staining was identified as brown cytoplasmic, with or without cell membrane staining. In all the 16 SCC cases, tumor cells failed to stain with CD10 in contrast to the stromal cells that showed CD10 expression in 13 cases (81%). In BCC cases, the expression of CD10 was noted in tumor cells in 10 cases (47.6%) and in stromal cells of 20 cases (95.24%). Most of CD10+ (7/10) BCC showed well-circumscribed deep margin, however, most of CD10- cases (9/11) showed infiltrating base (p=0.030). BCCs with infiltrating deep margins (12 cases) tended to show CD10 negative basaloid cells (9/12) and CD10 positive stromal cells (12/12) (p=0.0003). Conclusion : From our results we suggest that CD10 might be a useful immunohistochemical marker to differentiate between BCC and SCC. At least, if tumor cells were CD10 positive, this would favor BCC over SCC. Absence of CD10 in all the SCC and in infiltrating BCC together with its overexpression in the surrounding stromal cells might confer invasive properties to such tumors. However, its relation to other poor prognostic factors needs larger studies to be confirmed. Key Words : CD 10 -Immunostaining -Skin.

摘要

背景

CD10是一种锌依赖性金属肽酶,即常见急性淋巴细胞白血病抗原(CALLA)。尽管已对某些皮肤肿瘤中的CD10表达进行了研究,但据我们所知,关于其在皮肤上皮性肿瘤中表达的数据非常有限。我们旨在确定CD10在基底细胞癌(BCC)和鳞状细胞癌(SCC)中的免疫组化表达,并将其与这两种肿瘤的现有临床病理参数相关联。

患者与方法

本研究纳入16例SCC和21例BCC病例(17例实体型、2例硬斑病型和2例腺样基底型)。BCC病例分为12例镜下浸润性基底病例和9例边界清楚的基底病例。在每个病例中确定抗CD10在肿瘤和/或基质细胞中的定位。

结果

CD10阳性染色表现为棕色细胞质,可有或无细胞膜染色。在所有16例SCC病例中,肿瘤细胞未被CD10染色,而基质细胞在13例(81%)中显示CD10表达。在BCC病例中,10例(47.6%)肿瘤细胞和20例(95.24%)基质细胞中观察到CD10表达。大多数CD10阳性(7/10)的BCC显示边界清楚的深部边缘,然而,大多数CD10阴性病例(9/11)显示浸润性基底(p=0.030)。深部边缘浸润的BCC(12例)倾向于显示CD10阴性的基底样细胞(9/12)和CD10阳性的基质细胞(12/12)(p=0.0003)。

结论

根据我们的结果,我们认为CD10可能是区分BCC和SCC的有用免疫组化标志物。至少,如果肿瘤细胞CD10阳性,那么相对于SCC更支持BCC的诊断。所有SCC和浸润性BCC中CD10的缺失及其在周围基质细胞中的过表达可能赋予此类肿瘤侵袭性。然而,其与其他不良预后因素的关系需要更大规模的研究来证实。

关键词

CD10;免疫染色;皮肤

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验